CNBC's "Fast Money"

Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24

Jul 2, 2024
Pharma stocks decline after Biden criticizes high drug prices, while Tesla sees strong delivery numbers. Discussions on drug development costs, pricing strategies, and market trends in healthcare sector. Analyzes retail and consumer stocks performance, Tesla's upcoming RoboTaxi event, Paramount's potential sale, and impact of Citigroup downgrade on homebuilder stocks.
Ask episode
Chapters
Transcript
Episode notes
1
Intro
00:00 • 3min
2
Complexities in Drug Development Costs and Pricing Strategies
03:11 • 17min
3
Evaluation of Pharma Stocks and Market Trends in Healthcare Sector
20:26 • 2min
4
Analysis of Retail and Consumer Stocks Performance
22:00 • 9min
5
Tesla's RoboTaxi Event and Analyst Perspectives
31:19 • 7min
6
Discussion on Paramount's Potential Sale and Interest from Billionaire Barry Diller
38:06 • 2min
7
Impact of Citigroup Downgrade on Homebuilder Stocks
39:54 • 4min
8
Discussion on Consumer Discretionary Stocks and Upcoming Events
44:18 • 2min